Regentis Biomaterials RGNT
NYSE RGNT
$1.52 +0.05 (+3.40%)
As of: Oct 21, 2026 · 10:34 AM EDT

Regentis Biomaterials (RGNT) Operating Leases (2026)

Updated

Regentis Biomaterials (RGNT) reported Operating Leases of $18,000 for Q2 2026.

Analysis

Regentis Biomaterials (RGNT) Operating Leases (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.38 Bn 237.41 Bn 4.88 Bn
2 Abbott Laboratories 171.98 Bn 142.41 Bn 7.27 Bn
3 Danaher 162.99 Bn 146.80 Bn 3.61 Bn
4 Intuitive Surgical 150.28 Bn 129.70 Bn 1.96 Bn
5 Medtronic 119.92 Bn 85.17 Bn 6.34 Bn
6 Stryker 113.47 Bn 99.59 Bn 4.50 Bn
7 Boston Scientific 65.06 Bn 59.83 Bn 3.85 Bn
8 Becton Dickinson 53.40 Bn 50.55 Bn 2.32 Bn
9 Edwards Lifesciences 50.64 Bn 34.65 Bn 1.35 Bn
10 Regentis Biomaterials 861,450.87 861,450.87 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18,000.00
API Access

Regentis Biomaterials Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=RGNT&period=max&api_key=YOUR_API_KEY